0

CAPITAL SOLEIL 15 از شرکت LOREAL USA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CAPITAL SOLEIL 15 از شرکت LOREAL USA

New Drug Application (NDA): 021501

Company: LOREAL USA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CAPITAL SOLEIL 15 AVOBENZONE; ECAMSULE; OCTOCRYLENE 2%;3%;10% CREAM;TOPICAL Over-the-counter

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/02/2006 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Letter (PDF)

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021501s000LTR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021501_capital_soleil_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/21/2014 SUPPL-9 Manufacturing (CMC)

Label is not available on this site.

06/05/2007 SUPPL-3 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021501s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021501s003ltr.pdf

04/24/2007 SUPPL-1 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021501s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021501s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
06/05/2007 SUPPL-3

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021501s003lbl.pdf
04/24/2007 SUPPL-1

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021501s001lbl.pdf

CAPITAL SOLEIL 15

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

CREAM;TOPICAL; 2%;3%;10%
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD Application No. Company
CAPITAL SOLEIL 15 AVOBENZONE; ECAMSULE; OCTOCRYLENE 2%;3%;10% CREAM;TOPICAL Over-the-counter Yes 021501 LOREAL USA
برچسب‌ها:

نظرات کاربران